"trades at 1.4 times book which is an excellent metric for use in the financial industry. We are getting 6.5% dividend yield, and we are paying only 12 times earnings.

"flush with cash and returning value to shareholders through buybacks, dividends and highershare prices."

similair price-book valuation as Mega above.

"big enough and have enough resources that they can unearthnew revenue sources better that small or mid-sized rivals. In addition, the company trades at about 15 times estimated 2006 earnings, which is a low valuation for the business historically. And the shares really havent gone anywhere, so in a positive business cycle that means there is a chance for more upside. And the company has been buying back shares, has virtually no debt and a cost of capital of about 5%. So with return on equity in excess of 15%, that for us is a winning combination"

"management is very focused and the company has some exciting new products such as its very promising new weight-loss drug, Remonabant, which it will be selling in Europe soon and should recieve approval in the U.S."

"about 18 months ago there was a lot of uncertainty about the future of the business in light of changing viewer habits, alternative distribution channels underscored by Itunes and new content, all of which represented an opportunity for us"

No Analysis added

No Analysis added